The COVID-19 pandemic creates urgent need for rapid and accurate test for the novel coronavirus, but many countries lack of adequate supply of test kits.
In response to the outbreak, STM quickly assembled a special epidemic response team to carry out the research and development of SARS-CoV-2 nucleic acid detection kit. Within a short time, STM developed the new coronavirus nucleic acid detection kit that has met China CDC and WHO requirements. The kits have been clinically verified and showed excellent performance.
STM is a national high-tech enterprise, and the kits produced by STM have been CE certified by the European Union. SARS-CoV-2 nucleic acid detection kits have been donated to the United States, Europe and Middle East countries, totally 35,000 tests.
To meet the need of massive tests for the COVOD-19, the STM has achieved manufacture capacity of 2 million tests per day. STM has contributed to the global efforts to fight the COVID-19 pandemic.